1. Introduction {#sec1}
===============

Meningiomas represent the most frequently diagnosed primary central nervous system tumors in adults over 35 years, accounting for 33.8% in the USA between 2004 and 2006 \[[@B1]\]. Women are affected twice as commonly as men. According to the WHO classification of brain tumors \[[@B2]\], about 3% of meningiomas are malignant (WHO Grade III) and about 20% are atypical (WHO Grade II). The rest account for benign meningiomas (WHO Grade I).

While benign meningiomas in general are encapsulated and slowly growing, high-grade (Grade II/III) meningiomas often recur. Recurrence rates up to 80% for Grade II and up to 100% for Grade III meningiomas in 20 years have been reported \[[@B3]\]. Tumor grade, microscopical brain invasion, high mitotic count, and parasagittal location are negative prognostic factors of recurrence-free survival of patients with high-grade meningiomas \[[@B3], [@B4]\].

Most frequent presenting signs of high-grade meningioma patients are epileptic seizures, hemiparesis, and headache \[[@B5]\]. Mean duration of symptoms is 7.5 months prior to diagnosis \[[@B6]\]. There is no difference in duration of symptoms between primary and recurrent high-grade meningiomas \[[@B7]\]. So far, no type of presenting symptoms has been confirmed as a prognostic sign for meningioma recurrence. Both low- and high-grade meningioma patients may also present with behavior changes, frequently described as psychoorganic syndrome. Data about frequency and prognostic importance of preoperative behavior changes in patients with brain tumors, including patients with high-grade meningiomas, is missing \[[@B8]\].

In the present study, we analyzed 86 consecutive patients with primary high-grade meningiomas, treated at a single institution. Our aim was to assess the frequency, correlation with other factors, and prognostic importance of preoperative behavior changes in patients with primary high-grade meningiomas, which, to the best of our knowledge, have so far not been evaluated yet.

2. Materials and Methods {#sec2}
========================

2.1. Patients {#sec2.1}
-------------

86 consecutive patients with primary high-grade meningiomas diagnosed between 1990 and 2005 were included in the study. In the same time period, 790 primary benign meningiomas were diagnosed. All patients were surgically treated at the Department of Neurosurgery, University Medical Centre, Ljubljana, Slovenia. Selection of patients was based on original pathological reports. All original histological slides were reviewed when the original diagnosis was either Grade II or Grade III meningioma. Cases were reviewed without knowledge of clinical outcome and other clinical data. Microscopical brain invasion was assessed separately, and Ki67 proliferative index, which is a measure of cellular proliferation, was determined using routine immunohistochemical protocols.

Clinical data were retrieved from the patients\' medical records. The following clinical data were collected: tumor site (L/R), location and size, preoperative signs and symptoms, duration of symptoms, presence of brain edema on preoperative MR scans, tumor cleavability, and extent of surgical resection. Brain edema was graded as absent, mild, or severe. Data on cleavability were obtained from original operative reports with special emphasis on the tumor/brain interface. Meningiomas were classified as noncleavable when pial invasion was observed by the surgeon and cleavable when dissection in the extrapial plane could be performed \[[@B9]\].

Data on preoperative behavior changes were also retrieved from patients\' medical records. Patients were classified as having preoperative behavior changes if any data about behavior changes was noted in their history.

Follow-up data were collected for all patients, including recurrence-free survival (RFS; time from surgical resection to local recurrence) and overall survival (OS; time from surgical resection to death). The dates of patients\' death were collected from the Cancer Registry of Slovenia. No attempts were made to determine the cause of death.

2.2. Statistical Analysis {#sec2.2}
-------------------------

Statistical analysis was performed with SPSS 16.0 for Windows (SPSS Inc., Chicago, IL). The differences between groups in relation to other clinicopathological parameters were analyzed by the Mann-Whitney and the Kruskal-Wallis tests. Survival analysis was performed by the Cox model and survival curves were estimated using the Kaplan-Meier method. The final multivariate model was achieved using a stepwise backward elimination of nonsignificant variables.

3. Results {#sec3}
==========

86 consecutive patients with primary high-grade meningiomas were analyzed. Among 86 high-grade meningiomas cases, 76 meningiomas (88%) were Grade II and 10 (12%) were Grade III. 42 patients were male (49%) and 44 (51%) were female.

Out of 86 patients analyzed, clinical data was available for 83 patients. Behavior of 30 patients (34.9%) was described by their relatives as being changed. Out of these 30 patients, behavior changes were a *presenting symptom* in 12 cases (14%). Other patients presented with headaches (23 patients; 26.7%), hemiparesis (22 patients; 25.6%), epileptic fits (20 patients; 23.3%), and cranial nerves palsy (6 patients; 7%). In the group with behavior changes, patients were mostly suffering from aggressiveness, although other changes like apathy or hypersexuality were also described. Clinical and pathological characteristics of 86 high-grade meningiomas are shown in [Table 1](#tab1){ref-type="table"}.

Patients with behavior changes were older (mean 57.1 years) than patients with normal preoperative behavior (mean 53.7 years) (*P* = 0.017). Behavior changes tended to be more frequent in male patients: they were present in 19 out of 42 (47.5%) male and 11 out of 44 (27.5%) female patients (*P* = 0.066). They were found more frequently in larger tumors (*P* = 0.023) and were strongly associated with presence of brain edema (*P* = 0.006). Preoperative behavior changes were present in 31 (53.4%) cases with mild edema and in 17 (29.3%) cases with severe brain edema, while absent in all cases with no brain edema. They were also strongly correlated to tumor location, being more frequent in patients with tumors located frontally or frontobasally (*P* = 0.013). Preoperative behavior changes were less frequent in tumors located parasagittally (*P* = 0.008) and were not correlated to the site (L/R) of the tumor (*P* = 0.298). While there was a strong correlation of behavior changes with microscopic brain invasion (*P* = 0.015), no correlation with tumor cleavability as assessed by the surgeon was noticed. There was also no correlation between preoperative behavior changes and duration of symptoms, WHO Grade of the tumor, or Ki67 proliferation index. Correlation of several factors with preoperative behavior changes is shown in [Table 2](#tab2){ref-type="table"}.

Patients were followed until death or for a median of 96 months (range from 28 to 204 months). The 5- and 10-year recurrence-free survival (RFS) for the entire group of 86 high-grade meningiomas was 60% (95% CI, 48--71) and 55% (95% CI, 43--68), respectively. The 5- and 10-year overall survival (OS) for the entire group was 76% (95% CI, 67--86) and 56% (95% CI, 44--68), respectively. The univariate Cox analyses of the RFS and OS are shown in [Table 3](#tab3){ref-type="table"}. On multivariate analysis, brain invasion and parasagittal-falcine location were independent negative predictors of RFS, while male gender and parasagittal-falcine location were the only parameters associated with decreased OS. There were no significant differences in RFS or OS between patients with or without preoperative behavior changes.

4. Discussion {#sec4}
=============

Psychoorganic syndrome is a vague definition of behavior changes caused by a morphologically proven lesion in the brain. It has been described in patients with brain tumors, including meningiomas \[[@B10]--[@B13]\], revealing a dilemma whether neuroradiologic imaging should be a part of the routine diagnostic procedure in all psychiatric patients.

Most frequent behavior changes in patients with brain tumors are slowness, apathy, aggressiveness, hypersexuality, social inappropriateness, poor judgment, and lack of planning and rarely hallucinations and other psychotic symptoms \[[@B11]\]. Preoperative behavior changes are frequent findings in patients with *butterfly gliomas* (i.e., *glioblastoma multiforme* affecting both frontal lobes) or benign *olfactory meningiomas*\[[@B10], [@B11]\]. These two conditions affect both frontal lobes, causing malfunction of the prefrontal cortex. Several cases of unilateral frontal or frontobasal tumors causing behavior changes have been described \[[@B13]--[@B15]\]. Correlation with frontal or frontobasal location was also confirmed in our study, even if the tumor was unilateral. However, preoperative behavior changes are not limited to patients with frontal lobe tumors. Rare cases of unusual acquired aggressive and antisocial behavior correlated with frontal, temporal, thalamic, hypothalamic, or left parietal tumors have been reported in the literature \[[@B16]--[@B22]\]. So far, reviews have demonstrated no correlation between specific psychiatric symptoms and tumor location or histological type \[[@B23]\]. Since it was impossible to specify the behavior changes, no correlation between the type of behavior changes and the location of the tumor could be performed in our retrospective study.

We have shown that preoperative behavior changes, although not prognostically important, present a frequent finding in patients with high-grade meningiomas. According to our results, preoperative behavior changes mostly correlate with tumor invasion in the surrounding brain, as well as with brain edema. In high-grade meningioma patients, brain edema is more the result of tumor invasion than venous compression. Behavior changes do not correlate with other tumor malignancy properties, such as cellular proliferation, measured with the Ki67 proliferation index, neither do they correlate with the meningioma grade. Therefore, behavior changes may be the result of tumor cell invasion into the brain parenchyma as well as of brain edema forming in the invaded brain. Less probably, they may develop as the result of direct pressure on the brain parenchyma by a rapidly proliferating tumor.

Behavior changes may be the only initial manifestation of meningiomas \[[@B8]\]. Our study confirmed that in 14% they are a presenting symptom in patients with high-grade meningiomas. Since growth rate of high-grade meningiomas is relatively slow compared to malignant gliomas, the onset of behavior changes is slow, behavior changes are subtle, and patients with high-grade meningiomas may first be referred to psychiatrists \[[@B24]\]. In these cases, if radiological imaging is not performed, the accurate diagnosis may only emerge when the tumor has grown large enough to compress the brainstem and disturb other brain functions, such as consciousness \[[@B25]\].

A recent study reported significant risk for brain tumors in the first 1-2 years after admittance to a psychiatric hospital \[[@B26]\]. Nevertheless, studies have reported no raised incidence of intracranial tumors among patients manifesting schizophrenia, affective illness, or neurotic symptoms \[[@B27]\]. A very small incidence of positive radiological findings in psychiatric patients, except for brain atrophy, does not give good reason for routine CT and MRI brain scans in all hospitalized psychiatric patients \[[@B28]\].

In our study, we have showed that patients with high-grade meningiomas frequently manifest behavior changes, sometimes even as presenting symptoms. Since prognosis in these patients is worse than prognosis of patients with benign meningiomas---time to recurrence in malignant meningiomas is less than one year and no chemotherapy is effective---it is important not to delay the diagnosis. Early diagnosis gives the best chance of successful treatment to high-grade meningioma patients. The possibility of a patient suffering from behavior changes due to high-grade meningioma, initially being admitted to a psychiatric facility, illustrates how initial evaluation is critical. In these rare cases, transition from psychiatric to neurosurgical care management should be accelerated and surgical treatment should be performed immediately. In the process of diagnostics of patients with subtle behavior changes, the idea of high-grade meningioma must not be neglected.

Methodological shortcoming of this study is especially the retrospective nature of the study, without the use of a structured questionnaire to determine the nature of behavior changes. Correlation between the type of behavior changes and tumor location would add a lot to understanding the nature of psychiatric symptoms in patients with brain tumors.

5. Conclusions {#sec5}
==============

Preoperative behavior changes are frequent in patients harboring primary high-grade meningiomas. They correlate with tumor size, microscopic brain invasion, and brain edema. Preoperative behavior changes do not predict prognosis in patients with primary high-grade meningiomas.
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###### 

Clinical characteristics of 86 cases of high-grade meningiomas.

  Parameter                    *n*\* (%)
  ---------------------------- -----------
  Gender                       86
   Male                        42 (48.8)
   Female                      44 (51.2)
                               
  Age                          86
   Range, 13.5--85.4 years     ---
   Mean, 55.0 years            ---
   Median, 57.2 years          ---
                               
  Tumor size                   78
   Range, 2.0--8.5 cm          ---
   Mean, 4.9 cm                ---
   Median, 5.0 cm              ---
                               
  Tumor location               86
   Parasagittal-falcine        26 (30.2)
   Convexity                   35 (40.7)
   Base                        24 (27.9)
   Frontal/frontobasal         16 (18.6)
                               
  Tumor site                   86
   Left                        37
   Right                       31
   Bilateral                   18
                               
  Duration of signs/symptoms   80
   Range, 0--36 months         ---
   Mean, 7.5 months            ---
   Median, 4.0 months          ---
                               
  Presenting signs/symptoms    83
   Headache                    23 (25.9)
   Hemiparesis                 22 (36.6)
   Seizures                    20 (24.7)
   Behavior changes            12 (14)
   Cranial nerve palsy         6 (11.1)
                               
  Behavior changes             83
   Present                     30 (36.1)
   Absent                      53 (73.9)
                               
  Edema                        58
   Absent                      10 (17.2)
   Mild                        31 (53.4)
   Severe                      17 (29.3)
                               
  Cleavability                 42
   Cleavable                   18 (42.9)
   Noncleavable                24 (57.1)

\*The information on some parameters was not available for all patients.

###### 

Correlation of several factors with preoperative behavior changes.

  ------------------------------ -------
  Brain edema                    0.006
  Nonparasagittal location       0.008
  Frontal/frontobasal location   0.013
  Brain invasion                 0.015
  Age                            0.018
  Tumor size                     0.023
  Sex                            0.066
  Cleavability                   0.233
  Tumor site L/R                 0.298
  Ki67                           0.404
  Duration of symptoms           0.626
  WHO Grade                      0.650
  ------------------------------ -------

###### 

Univariate survival analysis of 86 high-grade meningiomas.

  Variable                                        *n*   Recurrence-free survival   Overall survival                              
  ----------------------------------------------- ----- -------------------------- ------------------ ------- ------ ----------- -------
  Sex (male versus female)                        86    1.9                        0.9--4.0           0.077   1.9    1.0--3.8    0.064
  Age (≥55 versus \<55)                           86    0.9                        0.5--1.8           0.776   3.19   1.5--6.7    0.002
  Location (parasagittal-falcine versus others)   86    2.3                        1.1--4.7           0.021   1.5    0.8--3.0    0.238
  WHO Grade (III versus II)                       86    2.0                        0.8--5.3           0.145   1.7    0.6--4.3    0.293
  Brain invasion (present versus absent)          37    7.2                        0.9--55.7          0.059   4.4    1.0--19.2   0.049
  Ki67 (\>4% versus ≤4%)                          86    2.7                        1.1--6.7           0.027   1.9    0.9--4.0    0.104
  Behavior changes (present versus absent)        83    0.7                        0.3--1.7           0.514   1.0    0.5--2.0    0.112
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